Purdue researchers apply new technique to manipulate virus, make it a possible cancer treatment
November 27, 2013
WEST LAFAYETTE, Ind. — Purdue University researchers successfully eliminated the native infection preferences of a Sindbis virus engineered to target and kill cancer cells, a milestone in the manipulation of this promising viral vector.
"This virus had been known to be a good vector for delivering therapeutic cargo, however it naturally infected all kinds of cells, and these diversions would compete with what we were instructing it to target," said Richard Kuhn, the Gerald and Edna Mann Director of Purdue's Bindley Biosciences Center. "We have now overcome a major challenge by not only inserting a targeting molecule of our choice, but also successfully stripping the virus of its native entry preferences. This was a big step in unlocking the potential of developing this virus into a platform for both targeted drug delivery, where it would sneak drugs inside cancer cells, and oncolytic virotherapy, where the virus itself destroys cancer cells."
- Elizabeth K. Gardner, Writer
May 27, 2015
Like most people, I never gave it much thought when I plugged my phone charger into an electrical socket. I certainly never thought about all the time, people, and resources it takes to power the lifestyle I took for granted.Read Full Story
May 20, 2015
A Purdue University program that brings high school students and teachers to campus for a week each summer to investigate energy problems and solutions is the recipient of Duke Energy Corp.'s Difference Maker award for 2015.Read Full Story
May 18, 2015
Purdue University and Red Hat Inc. (NYSE:RHT), the world's leading open-source solutions, are collaborating to create a two-year doctoral research position for Discovery Park's Research Center for Open Digital Innovation.Read Full Story